BMC Public Health 2007, 7:219 http://www.biomedcentral.com/1471-2458/7/219 Table 2: Selected questions and responses for NTCC Survey (n = 1480) Question/Responses 1. During your academic program to date, have you attended at least one lecture where tuberculosis (TB) was a primary focus? • Yes 2. Approximately how many hours of lecture/instruction on TB have you attended? • None • 1–2 hours • 3–4 hours • 5–6 hours • More than 6 hours 3. From which of the following teaching modalities have you received TB education? (mark all that apply) • None • Lecture • Case discussion at conference or case study • Seminar • Standardized patient • Game show format (e.g., Millionaire or Jeopardy) • Computer simulation • Completion of a module on a computer, followed by a series of questions answered on-line (computer based learning) • Other 4. Have you sought out and independently reviewed additional information about TB beyond requirements for a class or seminar? • Yes 5. Approximately how much total time have you spent outside of class learning about TB? • None • 1–2 hours • 3–4 hours • 5–6 hours • More than 6 hours General Knowledge Questions about Tuberculosis 6. Tuberculosis organisms are most commonly transmitted from person-to-person in which one of the following ways? • A. Blood and body fluids • B. Aerosol (correct answer) • C. Food • D. Fomites 7. What is the currently recommended method for administering tuberculin? • A. Intradermal injection (Mantoux) (correct answer) • B. Multi-prong method (Tine) • C. Subcutaneous injection • D. Inhalation 8. Which of the following is a contraindication to TB skin testing? • A. BCG vaccination • B. TB disease • C. Malnutrition • D. None of the above (correct answer) 9. Generally, what percentage of people in the U.S. who have LTBI and a normal immune system will go on to develop TB disease at some point in their lives? • A. 1% • B. 10% (correct answer) • C. 50% • D. 90% 10. Why is BCG NOT PART of the routine vaccination program in the United States? • A. The side effects are too severe • B. BCG is only effective for preventing adult pulmonary TB • C. BCG vaccination complicates surveillance for new TB infection (LTBI) (correct answer) • D. There is limited experience with BCG use in children N (%) 1307 (88.3) 61 (4.1) 585 (39.5) 528 (35.7) 165 (11.1) 141 (9.5) 36 (2.4) 1391 (94.0) 683 (46.1) 174 (11.8) 149 (10.1) 22 (2.2) 36 (2.4) 75 (5.1) 142 (9.6) 636 (43.0) 354 (23.9) 655 (44.3) 286 (19.3) 74 (5.0) 109 (7.4) 95 (6.4) 1352 (91.4) 8 (0.5) 20 (1.4) 959 (64.8) 52 (3.5) 437 (29.5) 31 (2.1) 519 (35.1) 388 (26.2) 44 (3.0) 526 (35.5) 364 (24.6) 944 (63.8) 140 (9.5) 29 (2.0) 210 (14.2) 115 (7.8) 945 (63.9) 188 (12.7) Page 4 of 8 (page number not for citation purposes)